Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
TRIBTrinity Biotech PLC
| Figure | TRIBTrinity Biotech PLCFY2024 · Dec |
|---|---|
| Revenue | $61.56M |
| Revenue, yoy | +8.3% |
| Net income | $31.79M |
| Net income, yoy | −32.4% |
| Net margin | -51.6% |
| Free cash flow | $4.60M |
| FCF margin | -7.5% |
| EPS, diluted | — |
Add another company.
Annual · FY2020–FY2024 · USD
From SEC EDGARSame fiscal periods, as filed